BOLT - Bolt Biotherapeutics Inc
Previous close
0.6899
0 0%
Share volume: 137,060
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.69
0.00
0.00%
Summary score
10%
Profitability
0%
Dept financing
7%
Liquidity
75%
Performance
6%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.94%
Return on assets
-9.08%
Return on sales
-1816.5%
Return on invested capital
-41.33%
Total debt ratio
21.33%
Debt ratio change over timeo
-1.53%
Current Ratio
9.34%
Quick Ratio
9.34%
Cash Position Ratio
9.09%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.91%
Return on assets
-11.28%
Return on sales
-843.37%
Return on invested capital
-45.7%
Total debt ratio
27.22%
Debt ratio change over timeo
-1.57%
Current Ratio
6.24%
Quick Ratio
6.24%
Cash Position Ratio
6%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-10.38%
Return on assets
-11.96%
Return on sales
-324.08%
Return on invested capital
-34.75%
Total debt ratio
27.11%
Debt ratio change over time
-1.51%
Current Ratio
5.68%
Quick Ratio
5.68%
Cash Position Ratio
5.46%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-72%
Return on assets
-76.98%
Return on sales
4819.18%
Return on invested capital
8.14%
Total debt ratio
-153.45%
Debt ratio change over time
-1.53%
Current Ratio
-27.03%
Quick Ratio
-27.03%
Cash Position Ratio
-26.38%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BOLT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.94% | 13.79% | 34.47% | 7.43% |
| Return on assets | -9.08% | 2.76% | 3.15% | 5.62% |
| Return on sales | -1816.5% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -41.33% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 21.33% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.53% | 308.97% | -6.99% | 1.18% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 6.24% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.24% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 5% | 12% | 28% |
| Short-term ratios | BOLT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.91% | 13.77% | 13.25% | 3.8% |
| Return on assets | -11.28% | 2.43% | 1.89% | 3.09% |
| Return on sales | -843.37% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -45.7% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 27.22% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.57% | 46.38% | -72.08% | 1.51% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 6.24% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.24% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 6% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 8% | 21% | 52% |